202222 Nov

Empatica Raises Series B Financing

Summary

In addition, the platform includes a proprietary Care software suite, secure cloud infrastructure, and clinically validated digital biomarkers. The platform and technology are used by thousands of institutional partners for research purposes, in studies examining stress, sleep, epilepsy, migraine, depression, addiction, and other conditions. In addition, the Platform includes Empatica’s proprietary Care software suite, secure cloud infrastructure, and clinically validated digital biomarkers. Each of Empatica’s digital biomarkers is based on trained algorithms that analyze sensor data in one-minute intervals, and have been rigorously validated in clinical studies conducted with diverse groups of participants. Empatica’s platform and technology are used by thousands of institutional partners for research purposes, in studies examining stress, sleep, epilepsy, migraine, depression, addiction, and other conditions.

Source: Finsmes

Funding

$0
Amount
Nov 22 2022
Date
-
Investor
Empatica
Company

Classifications

Companies